Clinical breast cancer
-
Clinical breast cancer · Oct 2007
Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
The frequency of aromatase inhibitor (AI)-associated arthralgia and/or bone pain in clinical practice is not known. ⋯ Aromatase inhibitor-associated pain is more frequent in patients not in clinical trials than previously appreciated in clinical trials. Improved patient education is needed, and prompt therapeutic management of pain is required to ensure continued drug treatment and improved quality of life.